Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide with Trastuzumab in HER2+ AR+ Breast Cancer
NCT02091960Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of enzalutamide in breast cancer, sponsored by Astellas Pharma. Started Sep 2014; status: completed.
02
Drugs
enzalutamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02091960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091960.